As the nation’s leading cause of death, cardiovascular disease is the subject of important research at UB’s New York State Center of Excellence in Bioinformatics & Life Sciences (CBLS).
Research related to heart failure and sudden death is conducted here, as is work focused on a range of leading-edge therapies and technologies, including:
Faculty and members of the Division of Cardiovascular Medicine are actively involved in advanced investigation funded through National Institutes of Health (NIH), the U.S. Department of Veterans Affairs (VA), and medical foundations and industry. They have led major multicenter clinical trials, as well as single-center patient-oriented investigation.
Preclinical research areas of focus include:
The division’s facilities include state-of-the-art laboratories for preclinical investigation, and are located in UB’s Clinical and Translational Research Center (CTRC), which sits above Kaleida Health’s Gates Vascular Institute (GVI). This proximity will allow for the delivery of collaborative clinical care, including patient evaluation and follow-up for clinical trials, and advanced clinical cardiovascular imaging.
Associate Director, Scientific Operations and Industry Engagement